DUSA Pharmaceuticals Inc. has failed to receive orphan drug designation from the FDA for its Levulan Photodynamic Therapy (PDT) system for multiple medical indications, with a concentration on dermatology. As a result, the company will close out the its associated pilot clinical trial.
California Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People with Disabilities Under MedicareAugust 6, 2010 11:35 am | by Bio-Medicine.Org | News | Comments
SACRAMENTO, Calif. , Aug. 6 /PRNewswire-USNewswire/ -- Providers of home medical equipment and services across California are proposing a fiscally responsible alternative to the mislabeled "competitive" bidding scheme currently under way in Medicare that will actually discourage...
Michigan Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities Under MedicareAugust 6, 2010 11:35 am | by Bio-Medicine.Org | News | Comments
ROCHESTER HILLS, Mich. , Aug. 6 /PRNewswire-USNewswire/ -- Providers of home medical equipment and services across Michigan are proposing a fiscally responsible alternative to the mislabeled "competitive" bidding scheme currently under way in Medicare that will actually discourage...
Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals ConferenceAugust 6, 2010 10:36 am | by Bio-Medicine.Org | News | Comments
MOUNTAIN VIEW, Calif. , Aug. 6 /- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that company Senior Vice President and Chief Financial Officer, August J. Moretti will present during the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference. The...
CHADDS FORD, Pa. , Aug. 6 /- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that it will present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference on Thursday, August 12, 2010 , at 8:00 a.m. EDT . Alan Levin, executive vice president and chief...
Shares of Alphatec Holdings Inc. plunged to a 52-week low Friday after the spinal device maker said sales are slowing down, and slashed its expectations for the rest of the year.In morning trading Alphatec shares dove $1.91, or 43.2 percent, to $2.51. Earlier they fell to an annual low of...
Drug distributor McKesson Corp. plans to open a distribution center in Caroline County, Va., that's expected to create 150 jobs.The new facility was announced Friday by McKesson officials, the Caroline County Board of Supervisors and Gov. Bob McDonnell.San Francisco-based McKesson will build...
Microchip Technology Inc., a leading provider of microcontroller, analog, and Flash-IP solutions, offers the four-member PIC24FJ256GB210 microcontroller family, which integrates USB for Embedded Host/Peripheral/On-the-Go and 96 Kbytes of RAM.
The Kontron 4U Backplane xPB-13E9P3 for PICMG 1.3-based system designs boasts comprehensive PCI and PCI Express Gen 2 support for full-height 4U systems.
Haydon Kerk Motion Solutions Inc, a leading manufacturer of precision linear motion products, offers an entire line of high output can stack linear actuators. The line include the 20, 25, and 35-mm frame sizes.
Syndax Pharmaceuticals Inc., a cancer therapeutics developer in Waltham, has raised $6 million of a planned $7 million securities offering. The company makes an oral HDAC inhibitor that is designed to aid a cancer patient's response to treatment by modifying tumor characteristics.
(University of British Columbia) Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a University of British Columbia study.
Federal Register: General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Postponement of MeetingAugust 6, 2010 6:31 am | by U.S. Food & Drug Administration | News | Comments
The meeting is postponed so that FDA can review and consider additional information that was submitted. A future meeting date will be announced in the Federal Register at a later date.
Federal Register: Draft Guidance for Industry and Food and Drug Administration Staff; Recommendations for Premarket Notifications for Lamotrigine and Zonisamide Assays; Availa...August 6, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments
This draft guidance document discusses information to be included in premarket notifications for lamotrigine or zonisamide assays. This draft guidance is not final nor is it in effect at this time.
The Standard High Torque Density Design (P/N DIH23-30-BFNA) delivers continuous power at levels approaching 1 HP continuous at speeds up to 20 K RPM.